NASDAQ:OFIX

Orthofix Medical (OFIX) Stock Price, News & Analysis

$13.43
+0.35 (+2.68%)
(As of 01:23 PM ET)
Today's Range
$13.06
$13.46
50-Day Range
$13.00
$14.64
52-Week Range
$9.57
$21.60
Volume
65,709 shs
Average Volume
403,070 shs
Market Capitalization
$502.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.50

Orthofix Medical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
15.4% Upside
$15.50 Price Target
Short Interest
Bearish
10.26% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.10mentions of Orthofix Medical in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.51) to ($0.69) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.60 out of 5 stars

Medical Sector

852nd out of 910 stocks

Surgical & Medical Instruments Industry

87th out of 95 stocks

OFIX stock logo

About Orthofix Medical Stock (NASDAQ:OFIX)

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

OFIX Stock Price History

OFIX Stock News Headlines

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
Orthofix (OFIX) Gets a Hold from JMP Securities
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
Orthofix Medical Inc. (OM2.F)
Q4 2023 Orthofix Medical Inc Earnings Call
Orthofix Medical Preliminary Q4 Net Sales Up 63.8% - Quick Facts
See More Headlines
Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
4/23/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:OFIX
CUSIP
N6748L10
Employees
1,634
Year Founded
1980

Price Target and Rating

Average Stock Price Target
$15.50
High Stock Price Target
$16.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+18.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Net Income
$-151,400,000.00
Pretax Margin
-19.91%

Debt

Sales & Book Value

Annual Sales
$746.64 million
Book Value
$16.11 per share

Miscellaneous

Free Float
35,649,000
Market Cap
$489.28 million
Optionable
Optionable
Beta
1.04

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Ms. Kimberley A. EltingMs. Kimberley A. Elting (Age 59)
    President of Global Orthopedics
    Comp: $766.67k
  • Mr. Kevin J. Kenny (Age 59)
    President of Global Spine Business
    Comp: $607.64k
  • Mr. Massimo Calafiore
    President, CEO & Director
  • Ms. Julie B. Andrews (Age 53)
    Chief Financial Officer
  • Mr. Roberto Donadello
    Senior Vice President of Global Operations
  • Dr. Frank Vizesi Ph.D.
    Chief Scientific Officer
  • Mr. Dan E. Yarbrough
    Vice President of Investor Relations
  • Ms. Jill Mason
    Interim Chief Ethics & Compliance Officer and VP of Corporate Counsel
  • Mr. Lucas S. Vitale (Age 47)
    Chief People & Business Operations Officer
  • Mr. Ehab M. Esmail (Age 52)
    Senior Vice President of Global Quality, Regulatory & Clinical Affairs

OFIX Stock Analysis - Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OFIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares.
View OFIX analyst ratings
or view top-rated stocks.

What is Orthofix Medical's stock price target for 2024?

4 brokers have issued 1 year price objectives for Orthofix Medical's stock. Their OFIX share price targets range from $15.00 to $16.00. On average, they predict the company's stock price to reach $15.50 in the next twelve months. This suggests a possible upside of 15.4% from the stock's current price.
View analysts price targets for OFIX
or view top-rated stocks among Wall Street analysts.

How have OFIX shares performed in 2024?

Orthofix Medical's stock was trading at $13.48 at the start of the year. Since then, OFIX shares have decreased by 0.4% and is now trading at $13.43.
View the best growth stocks for 2024 here
.

When is Orthofix Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our OFIX earnings forecast
.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc. (NASDAQ:OFIX) posted its quarterly earnings data on Tuesday, March, 5th. The medical device company reported ($0.59) earnings per share for the quarter, beating the consensus estimate of ($0.60) by $0.01. The medical device company earned $200.42 million during the quarter. Orthofix Medical had a negative trailing twelve-month return on equity of 10.63% and a negative net margin of 20.28%.

What ETFs hold Orthofix Medical's stock?

ETFs with the largest weight of Orthofix Medical (NASDAQ:OFIX) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE) and Invesco Nasdaq Future Gen 200 ETF (QQQS).iShares U.S. Medical Devices ETF (IHI).

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical updated its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $785.0 million-$795.0 million, compared to the consensus revenue estimate of $798.6 million.

What is Brad Mason's approval rating as Orthofix Medical's CEO?

32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).

How do I buy shares of Orthofix Medical?

Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OFIX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners